IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury

N. G. Frangogiannis, L. H. Mendoza, M. L. Lindsey, C. M. Ballantyne, L. H. Michael, C. W. Smith, M. L. Entman

Research output: Contribution to journalArticle

212 Citations (Scopus)

Abstract

Reperfusion of the ischemic myocardium is associated with a dramatic inflammatory response leading to TNF-α release, IL-6 induction, and subsequent neutrophil-mediated cytotoxic injury. Because inflammation is also an important factor in cardiac repair, we hypothesized the presence of components of the inflammatory reaction with a possible role in suppressing acute injury. Thus, we investigated the role of IL-10, an anti-inflammatory cytokine capable of modulating extracellular matrix biosynthesis, following an experimental canine myocardial infarction. Using our canine model of myocardial ischemia and reperfusion, we demonstrated significant up-regulation of IL-10 mRNA and protein in the ischemic and reperfused myocardium. IL-10 expression was first detected at 5 h and peaked following 96-120 h of reperfusion. In contrast, IL-4 and IL-13, also associated with suppression of acute inflammation and macrophage deactivation, were not expressed. In the ischemic canine heart, CD5-positive lymphocytes were the predominant source of IL-10 in the myocardial infarct. In the absence of reperfusion, no significant induction of IL-10 mRNA was noted. In addition, IL-12, a Th1-related cytokine associated with macrophage activation, was not detected in the ischemic myocardium. In vitro experiments demonstrated late postischemic cardiac-lymph-induced tissue inhibitor of metalloproteinases (TIMP)-1 mRNA expression in isolated canine mononuclear cells. This effect was inhibited when the incubation contained a neutralizing Ab to IL-10. Our findings suggest that lymphocytes infiltrating the ischemic and reperfused myocardium express IL-10 and may have a significant role in healing by modulating mononuclear cell phenotype and inducing TIMP-1 expression.

Original languageEnglish (US)
Pages (from-to)2798-2808
Number of pages11
JournalJournal of Immunology
Volume165
Issue number5
DOIs
StatePublished - Sep 1 2000

Fingerprint

Interleukin-10
Myocardium
Wounds and Injuries
Canidae
Reperfusion
Tissue Inhibitor of Metalloproteinase-1
Messenger RNA
Myocardial Infarction
Lymphocytes
Cytokines
Inflammation
Myocardial Reperfusion
Interleukin-13
Macrophage Activation
Lymph
Interleukin-12
Interleukin-4
Myocardial Ischemia
Extracellular Matrix
Interleukin-6

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Frangogiannis, N. G., Mendoza, L. H., Lindsey, M. L., Ballantyne, C. M., Michael, L. H., Smith, C. W., & Entman, M. L. (2000). IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. Journal of Immunology, 165(5), 2798-2808. https://doi.org/10.4049/jimmunol.165.5.2798

IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. / Frangogiannis, N. G.; Mendoza, L. H.; Lindsey, M. L.; Ballantyne, C. M.; Michael, L. H.; Smith, C. W.; Entman, M. L.

In: Journal of Immunology, Vol. 165, No. 5, 01.09.2000, p. 2798-2808.

Research output: Contribution to journalArticle

Frangogiannis, NG, Mendoza, LH, Lindsey, ML, Ballantyne, CM, Michael, LH, Smith, CW & Entman, ML 2000, 'IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury', Journal of Immunology, vol. 165, no. 5, pp. 2798-2808. https://doi.org/10.4049/jimmunol.165.5.2798
Frangogiannis, N. G. ; Mendoza, L. H. ; Lindsey, M. L. ; Ballantyne, C. M. ; Michael, L. H. ; Smith, C. W. ; Entman, M. L. / IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. In: Journal of Immunology. 2000 ; Vol. 165, No. 5. pp. 2798-2808.
@article{33987234f4f948be80f0198d3d113fe1,
title = "IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury",
abstract = "Reperfusion of the ischemic myocardium is associated with a dramatic inflammatory response leading to TNF-α release, IL-6 induction, and subsequent neutrophil-mediated cytotoxic injury. Because inflammation is also an important factor in cardiac repair, we hypothesized the presence of components of the inflammatory reaction with a possible role in suppressing acute injury. Thus, we investigated the role of IL-10, an anti-inflammatory cytokine capable of modulating extracellular matrix biosynthesis, following an experimental canine myocardial infarction. Using our canine model of myocardial ischemia and reperfusion, we demonstrated significant up-regulation of IL-10 mRNA and protein in the ischemic and reperfused myocardium. IL-10 expression was first detected at 5 h and peaked following 96-120 h of reperfusion. In contrast, IL-4 and IL-13, also associated with suppression of acute inflammation and macrophage deactivation, were not expressed. In the ischemic canine heart, CD5-positive lymphocytes were the predominant source of IL-10 in the myocardial infarct. In the absence of reperfusion, no significant induction of IL-10 mRNA was noted. In addition, IL-12, a Th1-related cytokine associated with macrophage activation, was not detected in the ischemic myocardium. In vitro experiments demonstrated late postischemic cardiac-lymph-induced tissue inhibitor of metalloproteinases (TIMP)-1 mRNA expression in isolated canine mononuclear cells. This effect was inhibited when the incubation contained a neutralizing Ab to IL-10. Our findings suggest that lymphocytes infiltrating the ischemic and reperfused myocardium express IL-10 and may have a significant role in healing by modulating mononuclear cell phenotype and inducing TIMP-1 expression.",
author = "Frangogiannis, {N. G.} and Mendoza, {L. H.} and Lindsey, {M. L.} and Ballantyne, {C. M.} and Michael, {L. H.} and Smith, {C. W.} and Entman, {M. L.}",
year = "2000",
month = "9",
day = "1",
doi = "10.4049/jimmunol.165.5.2798",
language = "English (US)",
volume = "165",
pages = "2798--2808",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "5",

}

TY - JOUR

T1 - IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury

AU - Frangogiannis, N. G.

AU - Mendoza, L. H.

AU - Lindsey, M. L.

AU - Ballantyne, C. M.

AU - Michael, L. H.

AU - Smith, C. W.

AU - Entman, M. L.

PY - 2000/9/1

Y1 - 2000/9/1

N2 - Reperfusion of the ischemic myocardium is associated with a dramatic inflammatory response leading to TNF-α release, IL-6 induction, and subsequent neutrophil-mediated cytotoxic injury. Because inflammation is also an important factor in cardiac repair, we hypothesized the presence of components of the inflammatory reaction with a possible role in suppressing acute injury. Thus, we investigated the role of IL-10, an anti-inflammatory cytokine capable of modulating extracellular matrix biosynthesis, following an experimental canine myocardial infarction. Using our canine model of myocardial ischemia and reperfusion, we demonstrated significant up-regulation of IL-10 mRNA and protein in the ischemic and reperfused myocardium. IL-10 expression was first detected at 5 h and peaked following 96-120 h of reperfusion. In contrast, IL-4 and IL-13, also associated with suppression of acute inflammation and macrophage deactivation, were not expressed. In the ischemic canine heart, CD5-positive lymphocytes were the predominant source of IL-10 in the myocardial infarct. In the absence of reperfusion, no significant induction of IL-10 mRNA was noted. In addition, IL-12, a Th1-related cytokine associated with macrophage activation, was not detected in the ischemic myocardium. In vitro experiments demonstrated late postischemic cardiac-lymph-induced tissue inhibitor of metalloproteinases (TIMP)-1 mRNA expression in isolated canine mononuclear cells. This effect was inhibited when the incubation contained a neutralizing Ab to IL-10. Our findings suggest that lymphocytes infiltrating the ischemic and reperfused myocardium express IL-10 and may have a significant role in healing by modulating mononuclear cell phenotype and inducing TIMP-1 expression.

AB - Reperfusion of the ischemic myocardium is associated with a dramatic inflammatory response leading to TNF-α release, IL-6 induction, and subsequent neutrophil-mediated cytotoxic injury. Because inflammation is also an important factor in cardiac repair, we hypothesized the presence of components of the inflammatory reaction with a possible role in suppressing acute injury. Thus, we investigated the role of IL-10, an anti-inflammatory cytokine capable of modulating extracellular matrix biosynthesis, following an experimental canine myocardial infarction. Using our canine model of myocardial ischemia and reperfusion, we demonstrated significant up-regulation of IL-10 mRNA and protein in the ischemic and reperfused myocardium. IL-10 expression was first detected at 5 h and peaked following 96-120 h of reperfusion. In contrast, IL-4 and IL-13, also associated with suppression of acute inflammation and macrophage deactivation, were not expressed. In the ischemic canine heart, CD5-positive lymphocytes were the predominant source of IL-10 in the myocardial infarct. In the absence of reperfusion, no significant induction of IL-10 mRNA was noted. In addition, IL-12, a Th1-related cytokine associated with macrophage activation, was not detected in the ischemic myocardium. In vitro experiments demonstrated late postischemic cardiac-lymph-induced tissue inhibitor of metalloproteinases (TIMP)-1 mRNA expression in isolated canine mononuclear cells. This effect was inhibited when the incubation contained a neutralizing Ab to IL-10. Our findings suggest that lymphocytes infiltrating the ischemic and reperfused myocardium express IL-10 and may have a significant role in healing by modulating mononuclear cell phenotype and inducing TIMP-1 expression.

UR - http://www.scopus.com/inward/record.url?scp=0034284216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034284216&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.165.5.2798

DO - 10.4049/jimmunol.165.5.2798

M3 - Article

C2 - 10946312

AN - SCOPUS:0034284216

VL - 165

SP - 2798

EP - 2808

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 5

ER -